Issue 1, 2020

Insights into structural and physicochemical properties required for β-hematin inhibition of privileged triarylimidazoles

Abstract

In this study, we investigated a series of triarylimidazoles, in an effort to elucidate critical SAR information pertaining to their anti-plasmodial and β-hematin inhibitory activity. Our results showed that in addition to the positional effects of ring substitution, subtle changes to lipophilicity and imidazole ionisability were important factors in SAR interpretation. Finally, in silico adsorption analysis indicated that these compounds exert their effect by inhibiting β-hematin crystal growth at the fast growing 001 face.

Graphical abstract: Insights into structural and physicochemical properties required for β-hematin inhibition of privileged triarylimidazoles

Article information

Article type
Research Article
Submitted
03 Oct 2019
Accepted
22 Oct 2019
First published
16 Dec 2019

RSC Med. Chem., 2020,11, 85-91

Insights into structural and physicochemical properties required for β-hematin inhibition of privileged triarylimidazoles

C. G. L. Veale, J. Jayram, S. Naidoo, D. Laming, T. Swart, T. Olivier, M. P. Akerman, K. A. de Villiers, H. C. Hoppe and V. Jeena, RSC Med. Chem., 2020, 11, 85 DOI: 10.1039/C9MD00468H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements